Circulating pro- and antioxidant factors in iron and porphyrin metabolism disorders.
BACKGROUND
Porphyria cutanea tarda and haemochromatosis are taken to be spontaneous human models of oxidative cellular damage, with an increased risk of fibrosis and cancer evolution.


OBJECTIVE
To define the relative pro-oxidant roles of porphyrin and iron, in their different molecular forms, and their effects on antioxidant biological systems.


METHODS
A group of 17 patients with porphyria cutanea tarda and a group of 14 patients with primary and secondary haemochromatosis, were compared with 21 healthy controls.


METHODS
Plasma retinol, tocopherol, alpha- and beta-carotene, ascorbic acid, glutathione, malonyldialdehyde and red blood cell free iron were determined using high performance liquid chromatography.


RESULTS
Only a modest increase in iron stores was demonstrated in the porphyria cutanea tarda group; in the haemochromatosis patients ferritin levels were almost seven times higher. By contrast, there was a sharp and virtually identical increase in red blood cell free iron and malonyldialdehyde in both the patient groups. A significant reduction was observed in retinol, alpha-, beta-carotene and red blood cell glutathione levels being more marked in porphyria cutanea tarda than in haemochromatosis patients.


CONCLUSIONS
The study confirms the strong pro-oxidant effects of porphyrins in vivo, through an induction of the free toxic iron form, even though the total iron pool is not greatly expanded. The additional free-iron and porphyrin oxidant effects are documented both in red blood cell and plasma in the porphyria cutanea tarda group. It confirmed that aging exerts a negative influence in terms of pro- and antioxidant balance in all cases, but particularly in the haemochromatosis group.
Rocchi
E
E
Department of Internal Medicine, University of Modena, Italy. rocchi.emilio@unimo.it
Casalgrandi
G
G
Masini
A
A
Giovannini
F
F
Ceccarelli
D
D
Ferrali
M
M
Marchini
S
S
Ventura
E
E
D000975:Antioxidants; D005260:Female; D006432:Hemochromatosis / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017119:Porphyria Cutanea Tarda / Q000097:blood*; D017382:Reactive Oxygen Species
D000975:Antioxidants; D017382:Reactive Oxygen Species